Crossmark

Regular human insulins versus rapid-acting insulin analogues in children and adolescents with type 1 diabetes: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis

Crossref DOI link: https://doi.org/10.1186/s13643-024-02729-4

Published Online: 2025-01-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Petersen, Johanne Juul https://orcid.org/0000-0001-9837-1958
Juul, Sophie

Kamp, Caroline Barkholt

Faltermeier, Pascal

Sillassen, Christina Dam Bjerregaard

Dos Santos, Tiago Jeronimo

Jakobsen, Janus Christian
License Information

Text and Data Mining valid from 2025-01-06

Version of Record valid from 2025-01-06
More Information

Article History

Received: 1 February 2024

Accepted: 30 November 2024

First Online: 6 January 2025

Ethics approval and consent to participate

: Not applicable.

: All authors approve publication of the protocol.

: CDBS’s husband is employed at Novo Nordisk, Kalundborg, Denmark, as “facility manager” since September 1, 2024.

Document is current

Any future updates will be listed below